Many studies have been devoted to the inhibitory action of various metabolite analogues on microbial growth. In most of this work, however, such nonpathogens as the yeasts, lactobacilli, and Escherichia coli have served as the test organism and there has been little attempt to correlate or extend the studies to pathogenic bacteria, especially those organisms synthesizing their own growth factors.
Many studies have been devoted to the inhibitory action of various metabolite analogues on microbial growth. In most of this work, however, such nonpathogens as the yeasts, lactobacilli, and Escherichia coli have served as the test organism and there has been little attempt to correlate or extend the studies to pathogenic bacteria, especially those organisms synthesizing their own growth factors.
In a recent study we have shown the results obtained when 96 metabolite antagonists were tested on two virulent strains of the tubercle bacillus, an organism capable of synthesizing its own vitamins (Pope and Smith, 1949) . Analogues of biotin and p-minobenzoic acid were found to exert a specific bacteriostatic action on the organism, and Drea (1948) has found that an analogue of phenylalanine, ,8-2-thienylalanine, is inhibitory for the tubercle bacillus at high concentrations.
With such findings as evidence that an inhibition of synthesis or utilization of a metabolite may be produced in a pathogenic organism that has the inherent ability to synthesize its own vitamins and amino acids from simple substances contained in the culture medium, further studies of this kind are indicated.
The present paper reports the inhibition of growth of the tubercle bacillus by five analogues of phenylalanine and the effect of phenylalanine on this inhibition.
The compounds studied were ,3-2-thienylalanine, fB-3-thienylalanine, j%2-furylalanine, a-amino-phenylmethane sulfonic acid, and ,B-hydroxyphenylalanine.
MATERIALS AND METHODS
A virulent human strain of Mycobacterium tuberculosis, H37Rv, was used exclusively in these studies. Stock cultures of the organism were maintained on Proskauer-Beck synthetic medium, which also served as substrate in the test cultures. Twenty-ml aliquots containing serial dilutions of the drug under study were inoculated with one loopful of organisms from an actively growing culture. Duplicate tests were run at each concentration level, and four control cultures always were included with each series. Repeat tests were made on all compounds showing any degree of inhibitory action at levels up to 100 mg per cent. After establishment of the minimal effective concentration (MEC) of the drug required to prevent surface growth of the organism completely, phenylalanine was tested for its ability to neutralize the bacteriostatic effect, and the antibacterial index was determined. As used here the antibacterial index is expressed as C, in which CM C, signifies the minimal effective molar concentration of analogue required to Aided by a research grant from the National Tuberculosis Association. 223
HILDA POPE inhibit surface growth of the organism completely, and CM is the molar concentration of related metabolite required to neutralize the inhibitory effect.
The following amino acids also were tested for reversing activity: alanine, arginine, aspartic acid, cystine, glutamic acid, histidine, isoleucine, leucine, norleucine, lysine, methionine, proline, serine, tryptophan, tyrosine, and valine.
Because of the nature of the growth of the tubercle bacillus as a pellicle on the surface of the medium, growth was graded after a 6-week growth period in terms of 4, +, ++, +++, and ++ + +. All cultures were coded and readings made by the same investigator.
The five analogues of phenylalanine tested by the foregoing procedure include (3-2-thienylalanine, 3-3-thienylalanine, (3-2-furylalanine, a-amino-phenylmethane sulfonic acid, and (3-hydroxyphenylalanine. Additional tests were made with 3-3-thienylalanine using as substrate Dubos' sorbitan monooleate medium without albumin. The medium also served as the diluent in preparing serial dilutions of the drug and phenylalanine. The inoculum consisted of 0.1 ml of a homogeneous 7-day culture of H37Rv grown in the basic sorbitan monooleate medium. Tests were conducted in 18-mm matched test tubes containing a total volume of 10 ml. Each culture tube was shaken daily to resuspend the organisms, which tended to settle out, and to break up the small clumps that formed. A homogeneous suspension of organism was thus obtained, and the extent of growth was determined daily by turbidity measurements on the "lumetron" photocolorimeter. Table 1 shows the magnitude of inhibition of the H37Rv tubercle bacillus by the different analogues of phenylalanine. Four of the compounds inhibited growth of the bacillus, but in only three of the cases, #-3-thienylalanine, B-2-thienylalanine, and j-2-furylalanine, could the inhibition be overcome by phenylalanine.
RESULTS
3-3-Thienylalanine was by far the most effective of the analogues tested, 5 mg per cent preventing completely surface growth. With #-hydroxyphenylalanine at concentrations up to 100 mg per cent no inhibitory activity was observed. Table 2 presents data on the neutralizing effect of varying concentrations of phenylalanine on the bacteriostasis produced by three of the analogues at their MEC. j3-3-Thienylalanine was found to be not only the most effective inhibitor on the basis of the low concentrations that prevented growth of the organism but also because of the low antibacterial index. This drug was found to have an index of 1.0 as compared with 3.6 and 1.4 for B-2-thienylalanine and fr2-furylalanine, respectively. Concentrations of phenylalanine up to 100 mg per cent failed to reverse the inhibitory effect of a-amino-phenyhnethane sulfonic acid. When sorbitan monooleate medium was used as the basic substrate, complete bacteriostasis was produced by ,-3-thienylalanine at 1 mg per cent, there being .--.
-.
a sharp rise in activity of the compound above the 0.25 mg per cent level (figure 1). Correspondingly lower concentrations of phenylalanine were required to neutralize the toxic effect of the analogue, but the antibacterial index at the various levels approximated that obtained with pellicle growth on the Proskauer-Beck medium. Table 3 gives data on the effect of different concentrations of ,B-3-thienylalanine and phenylalanine on the growth of the H37Rv tubercle bacillus.
Growth of tubercle bacilli in TABLE 3 sorbitan monooleate medium containing g3-8-thienylalanine In addition to phenylalanine, five other amino acids also were able to neutralize the inhibition produced by 5-3-thienylalanine. Of these, tyrosine was the most effective, with higher concentrations of leucine, isoleucine, norleucine, and tryptophan being required to produce a comparable effect. Fifteen mg per cent of tyrosine neutralized the effect of 5 mg per cent of ,3-3-thienylalanine, in comparison with 5 mg per cent of phenylalanine and 50 mg per cent of the other effective amino acids.
DISCUSSION
Phenylalanine is among the amino acids synthesized by the tubercle bacillus (Tamura, 1913) . The finding that three of the phenylalanine analogues tested served as inhibitors in the metabolism of this amino acid in the tubercle bacillus is further evidence that even in organisms that have the inherent ability of elaborating their own amino acids and growth factors, a nutritional deficiency may be produced by a blocking of either the synthesis or the utilization of an essential metabolite.
,-3-Thienylalanine was found to be the most effective inhibitor tested and may be classified as a true "antiphenylalanine" since phenylalanine was more active in neutralizing the inhibitory action of the analogue than any of the other amino acids. The finding that tyrosine, leucine, isoleucine, norleucine, and tryptophan are also effective in this respect is interesting in view of similar findings by Dittmer et al. (1946) and Clark and Dittmer (1948) in regard to their ability to neutralize inhibition in Saccharomyces cerevisiae and Escherichia coli produced by ,-2-thienylalanine and,-2-furylalanine. The mode of action of these amino acids in the phenylaline metabolism of the tubercle bacillus is unknown, but they may possibly serve as precursors in phenylalanine synthesis just as tryptophan has been suggested as a precursor of phenylalanine for E. coli by Beerstecher and Shive (1946) .
The difference in activity between ,3-2-thienylalanine and j-3-thienylalanine emphasizes again the importance of molecular configuration in the determination of the antibacterial activity of a compound. The greater activity of ,9-3-thienylalanine would seem to justify additional studies with this antagonist.
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Five analogues of phenylalanine have been tested in vitro on the H37Rv strain of tubercle bacillus and the degree of inhibition determined. 3-3-Thienylalanine, #-2-thienylalanine, ,-2-furylalanine, and a-amino-phenylmethane sulfonic acid inhibited growth of the organism, but the activity of only the first three compounds was neutralized by phenylalanine.
jl-3-Thienylalanine was the most toxic compound tested, 5 mg per cent completely preventing growth in the Proskauer-Beck medium, and 1 mg per cent in the sorbitan monooleate medium.
In addition to phenylalanine, tyrosine, leucine, isoleucine, norleucine, and tryptophan counteracted the toxicity of (l-3-thienylalanine although higher concentrations of these amino acids were required.
